Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Steven Burrill


  • Director at Depomed Inc (DEPO), 2013-12-12
  • Large Shareholder at Diadexus Inc. (DDXS), 2013-11-04
  • Director at Targacept Inc (TRGT), 2012-08-01
  • Large Shareholder, Director at R&r Acquisition Vi Inc (NONE), 2012-02-16
  • Director at Pharmasset Inc (VRUS), 2010-10-18
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
DEPO $8.09 69,250 Director 40,000 2011-05-13 Filing
DEPO $8.25 87,000 Director 40,000 2011-05-12 Filing
TRGT $23.88 33,052 Director 0 2011-05-12 Filing
TRGT $24.13 2,000 Director 0 2011-05-10 Filing
TRGT $24.04 16,948 Director 0 2011-05-10 Filing